Ganirelix acetate inj Rx
Generic Name and Formulations:
Ganirelix acetate 250mcg per 0.5mL; soln for SC inj.
Merck & Co., Inc.
Indications for Ganirelix acetate inj:
Inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
After initiating FSH on day 2 or 3 of the cycle: 250mcg once daily SC during the mid to late follicular phase. Continue until the day of hCG.
Pregnancy (Cat.X). Nursing mothers.
Do complete gynecological and endocrinological exam first. Latex allergy.
Abdominal pain (gynecological), fetal death, headache, ovarian hyperstimulation syndrome, vaginal bleeding, injection site reactions, nausea, GI pain.
Prefilled syringe—1, 5, 50
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders